Brain type natriuretic peptide (BNP)—A marker of new millennium in diagnosis of congestive heart failure |
| |
| Authors: | Arun Raizada Suman Bhandari Muzaiyan Ahmed Khan Harsh Vardhan Singh Sherin Thomas Vikram Sarabhai Neelima Singh Naresh Trehan |
| |
| Institution: | (1) Department of Biochemistry, People's College of Dental Sciences & Research Centre, 462018 Bhopal;(2) Department of Pathology, Hindu Rao Hospital, 110007 Delhi;(3) Department of Biochemistry, G. R. Medical College, 474002 Gwalior;(4) Department of Clinical Biochemistry and Cardiology, Escorts Heart Insitute & Research Centre, 110025 New Delhi |
| |
| Abstract: | The burden of disease in patients with congestive heart failure is high. The future of BNP looks promising as it may be a
better diagnostic tool for the diagnosis of CHF in developing countries in new millennium. Natriuretic peptide hormones, a
family of vasoactive peptides with many favourable physiological properties, have emerged as important contenders for development
of diagnostic tools and therapeutic agents in cardiovascular disease. Measurement of B-type natriuretic peptide has become
as an easy-to-perform bedside test. The clinical and diagnostic significance of the measurement of plasma Nt-proBNP in the
diseases of the cardiovascular system with particular emphasis on the assessment of patients with heart failure and their
effects on predicting survival rate. The plasma levels of Nt-proBrain Natriuretic peptide responds more vigorously after myocardial
infarction than those of other natriuretic peptides. This article is an attempt to give a short overview on the utility of
BNP-blood levels for the diagnosis and treatment of heart failure |
| |
| Keywords: | Congestive heart failure B-type Natriuretic peptide Amino terminal pro brain natriuretic peptide Left ventricular ejection fraction Myocardial Infarction |
| 本文献已被 SpringerLink 等数据库收录！ |
